Myeloma Incidence and Mortality by Year, Black Individuals, New York City, 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 91 9.0 7.1-11.2 45 11.7 8.2-16.0 46 7.3 5.2-9.9 50 5.2 3.7-6.9 19 4.2 2.4-6.7 31 5.5 3.6-8.0
1977 92 8.7 6.9-10.9 41 10.4 7.0-14.9 51 7.8 5.7-10.4 62 6.1 4.5-8.0 28 7.9 4.9-11.9 34 5.2 3.5-7.3
1978 92 8.7 6.9-10.8 52 14.0 10.0-19.0 40 5.8 4.0-7.9 45 4.1 2.9-5.6 25 6.8 4.1-10.5 20 2.7 1.6-4.2
1979 106 8.8 7.1-10.7 48 9.2 6.6-12.4 58 8.3 6.2-10.8 56 5.0 3.7-6.6 23 5.1 3.1-7.9 33 4.9 3.2-6.9
1980 120 10.2 8.3-12.4 48 11.4 8.1-15.6 72 9.7 7.5-12.4 77 6.7 5.2-8.5 34 8.1 5.3-11.6 43 5.9 4.2-8.0
1981 112 9.1 7.4-11.1 49 10.2 7.3-13.7 63 8.5 6.4-11.0 56 4.9 3.6-6.5 21 5.1 2.9-8.1 35 4.8 3.3-6.8
1982 119 9.7 7.9-11.7 52 10.7 7.7-14.3 67 9.0 6.8-11.5 85 7.0 5.5-8.7 42 8.9 6.1-12.4 43 5.8 4.2-7.9
1983 120 9.2 7.6-11.2 49 9.2 6.6-12.3 71 9.1 7.0-11.5 76 6.2 4.8-7.8 28 6.0 3.8-8.9 48 6.2 4.5-8.3
1984 132 10.4 8.6-12.4 54 11.8 8.5-15.9 78 9.7 7.6-12.1 89 7.0 5.5-8.7 30 5.9 3.8-8.6 59 7.5 5.6-9.8
1985 134 9.7 8.1-11.6 54 11.6 8.3-15.5 80 9.0 7.1-11.3 80 5.9 4.6-7.4 38 8.0 5.4-11.3 42 4.8 3.4-6.6
1986 134 9.5 7.9-11.3 60 11.7 8.6-15.3 74 8.3 6.5-10.5 79 6.0 4.7-7.5 34 6.9 4.6-9.8 45 5.4 3.9-7.3
1987 125 8.5 7.0-10.2 60 10.7 8.0-14.0 65 7.1 5.5-9.1 77 5.4 4.2-6.8 40 7.6 5.2-10.7 37 4.1 2.9-5.7
1988 109 7.2 5.9-8.8 48 8.3 5.9-11.2 61 6.6 5.0-8.5 63 4.4 3.4-5.7 29 5.6 3.5-8.2 34 3.8 2.6-5.3
1989 134 9.5 7.9-11.3 62 12.0 8.9-15.8 72 8.1 6.3-10.2 61 4.5 3.4-5.8 28 6.2 3.9-9.1 33 3.7 2.5-5.2
1990 139 8.8 7.3-10.4 56 10.6 7.7-14.1 83 8.2 6.5-10.2 65 4.6 3.5-5.9 26 5.7 3.6-8.5 39 4.2 3.0-5.7
1991 145 9.7 8.1-11.4 47 8.7 6.2-11.8 98 10.2 8.2-12.5 84 5.7 4.5-7.1 33 6.6 4.3-9.5 51 5.4 4.0-7.1
1992 180 11.2 9.6-13.0 81 14.1 10.9-17.8 99 9.8 7.9-11.9 82 5.1 4.0-6.3 30 5.7 3.6-8.4 52 5.0 3.7-6.6
1993 131 8.0 6.6-9.5 55 8.4 6.2-11.0 76 7.5 5.9-9.4 75 4.8 3.8-6.1 32 6.0 3.9-8.6 43 4.3 3.1-5.8
1994 148 9.2 7.7-10.8 62 10.6 8.0-13.8 86 8.5 6.7-10.5 78 4.9 3.9-6.2 27 4.4 2.8-6.6 51 5.1 3.8-6.7
1995 163 9.8 8.3-11.5 68 11.5 8.7-14.8 95 9.0 7.3-11.0 108 6.6 5.4-8.0 45 7.6 5.4-10.4 63 6.0 4.6-7.7
1996 161 9.3 7.9-10.8 67 10.1 7.7-13.0 94 8.7 7.0-10.7 81 4.8 3.8-6.0 38 6.4 4.4-8.9 43 4.0 2.9-5.4
1997 177 10.1 8.6-11.7 75 11.1 8.6-14.1 102 9.4 7.6-11.4 87 5.1 4.1-6.3 39 6.5 4.5-9.0 48 4.4 3.3-5.9
1998 181 10.2 8.7-11.8 78 11.7 9.1-14.8 103 9.3 7.6-11.3 76 4.4 3.4-5.5 26 4.1 2.6-6.1 50 4.5 3.3-6.0
1999 186 10.3 8.8-11.9 66 9.1 6.9-11.7 120 10.6 8.8-12.7 84 4.6 3.7-5.8 31 4.4 2.9-6.3 53 4.7 3.5-6.1
2000 193 10.1 8.7-11.6 76 10.3 7.9-13.0 117 9.8 8.1-11.8 71 4.1 3.2-5.1 17 2.8 1.6-4.6 54 4.8 3.6-6.2
2001 213 11.0 9.5-12.6 84 11.6 9.1-14.5 129 10.8 9.0-12.8 87 4.7 3.7-5.8 36 5.4 3.7-7.6 51 4.3 3.2-5.6
2002 218 11.1 9.6-12.7 87 12.1 9.5-15.0 131 10.7 8.9-12.7 107 5.6 4.6-6.8 43 5.7 4.0-7.8 64 5.4 4.2-6.9
2003 228 11.6 10.1-13.3 93 13.0 10.3-16.1 135 10.9 9.2-13.0 89 4.5 3.6-5.5 38 4.8 3.3-6.8 51 4.2 3.1-5.5
2004 212 10.2 8.9-11.7 87 10.7 8.5-13.3 125 9.8 8.2-11.7 94 4.8 3.9-5.9 39 5.3 3.7-7.3 55 4.6 3.4-6.0
2005 252 12.1 10.6-13.7 109 13.5 11.0-16.4 143 11.1 9.3-13.1 87 4.3 3.4-5.3 35 4.6 3.1-6.5 52 4.1 3.0-5.4
2006 255 12.3 10.8-13.9 119 14.8 12.2-17.8 136 10.6 8.9-12.5 80 3.9 3.1-4.9 34 4.4 3.0-6.2 46 3.6 2.6-4.8
2007 222 10.7 9.3-12.2 100 13.0 10.4-15.9 122 9.4 7.8-11.2 109 5.2 4.3-6.3 48 6.0 4.3-8.0 61 4.7 3.6-6.0
2008 293 13.4 11.9-15.0 136 16.5 13.7-19.6 157 11.6 9.8-13.5 76 3.7 2.9-4.6 31 4.0 2.7-5.7 45 3.4 2.5-4.6
2009 314 14.2 12.7-15.9 156 17.8 15.0-20.9 158 11.8 10.0-13.8 93 4.3 3.5-5.3 52 6.2 4.6-8.2 41 3.1 2.2-4.2
2010 307 13.6 12.1-15.2 159 18.7 15.7-22.0 148 10.7 9.0-12.6 101 4.7 3.8-5.7 45 5.7 4.1-7.7 56 4.1 3.1-5.4
2011 352 15.0 13.5-16.7 173 18.9 16.1-22.1 179 12.8 11.0-14.8 98 4.3 3.5-5.2 47 5.5 4.0-7.4 51 3.5 2.6-4.6
2012 352 14.9 13.3-16.5 151 16.8 14.1-19.8 201 13.8 11.9-15.8 95 4.0 3.2-4.9 47 5.0 3.6-6.7 48 3.3 2.4-4.4
2013 336 13.6 12.1-15.1 165 17.6 14.9-20.6 171 11.3 9.6-13.1 96 3.9 3.2-4.8 52 5.6 4.1-7.5 44 3.0 2.2-4.0
2014 365 14.7 13.2-16.4 171 17.5 14.9-20.4 194 13.0 11.2-15.0 100 4.3 3.5-5.2 49 5.6 4.1-7.4 51 3.5 2.6-4.6
2015 339 13.3 11.9-14.8 162 15.9 13.5-18.7 177 11.6 9.9-13.4 127 5.0 4.2-6.0 59 6.4 4.8-8.3 68 4.3 3.3-5.4
2016 381 14.5 13.0-16.1 173 16.8 14.3-19.6 208 13.1 11.3-15.0 125 5.0 4.1-5.9 57 5.8 4.4-7.6 68 4.5 3.5-5.7
2017 385 14.7 13.3-16.3 171 16.7 14.2-19.5 214 13.4 11.6-15.3 117 4.4 3.7-5.3 52 5.3 3.9-7.1 65 4.0 3.0-5.1
2018 363 13.1 11.8-14.6 150 13.3 11.1-15.6 213 12.9 11.2-14.9 97 3.5 2.9-4.3 44 4.3 3.1-5.8 53 3.1 2.3-4.1
2019 359 13.2 11.8-14.6 185 17.1 14.6-19.8 174 10.8 9.2-12.6 104 3.7 3.0-4.5 52 4.8 3.5-6.3 52 2.9 2.2-3.9
2020 307 11.1 9.9-12.5 139 12.7 10.6-15.0 168 10.2 8.7-11.9 72 2.6 2.0-3.3 28 2.5 1.7-3.7 44 2.7 2.0-3.7

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.